Blog
19 November 2026

New poll bolsters effort to raise awareness about lung cancer risk

Author(s):
Nadia Litterman
Dr Nadia Litterman
Executive Director of the Susan Wojcicki Foundation

Nadia Litterman, PhD, serves as Executive Director of the Susan Wojcicki Foundation, where she leads the foundation’s scientific strategy, organisational development, and cross-sector partnerships to advance innovation in lung cancer early detection and prevention.

Low-dose CT screening can detect lung cancer at an early stage and save lives. Yet in 2024, roughly 1 in 4 screening-eligible adults in the United States were up to date on lung cancer screening, according to an article published in JAMA Internal Medicine – a rise of 6 percentage points since 2022.  This number has improved in recent years, but it is still not enough. American Cancer Society researchers estimate that screening everyone who is eligible could prevent about 62,110 lung cancer deaths over five years.

When the Vatican announced in October that Pope Leo XIV had been diagnosed with lung cancer, the disease became a topic of conversation around the world. His cancer was found early by chance during exams for another reason, according to his surgeon. But most lung cancers are found at advanced stages.

Moments like these are a chance to ask what stands in the way of more people getting screened earlier.

At the Susan Wojcicki Foundation, we think the answer comes down to three questions. Who is eligible? Who knows they should be screened? And who actually gets screened? These are distinct but interconnected challenges, and addressing each will be essential to detecting more lung cancers earlier.

Many people at risk don't qualify

Screening guidelines in the United States recommend annual low-dose CT scans for people ages 50 to 80 who currently smoke or quit within the past 15 years, with a smoking history of at least 20 pack-years. A pack-year is one pack a day for one year, so 20 pack-years is roughly a pack a day for two decades.

Those criteria are based on trial evidence, and they have saved lives. Newer research has made clear that they also leave people out. By current guidelines, 1 in 2 people diagnosed with lung cancer would not have been eligible for screening. That includes people who quit more than 15 years ago or smoked less than 20 pack years, people diagnosed before 50, and people who never smoked.

The result is that lung cancer is too often found by chance, on an X-ray after an accident or on imaging done for something else. We are glad when it is caught, but we don't think luck should be the plan. This is why the Foundation is working to help redefine risk and expand eligibility for screening.

The impact of misunderstanding and stigma

Lung cancer is still widely seen as a “smoker's disease.”

That belief causes harm in two directions. People who never smoked may assume screening isn't relevant to them. People with a smoking history may feel they have lost the right to ask for care. Both groups end up with less access to earlier detection. Understanding who is at risk, and why, is central to the Foundation's work.

That’s why the Foundation asked Ipsos to conduct a national public opinion poll of more than 2,000 U.S. adults late last month. And what we learned surprised us.

Our poll revealed an important disconnect: While most Americans know that lung cancer can affect anyone, far fewer recognise its impact or are familiar with screening recommendations. A majority (84%) of poll respondents know lung cancer can occur in people who have never smoked, and that screening can find it before it spreads (80%). But only 27% of respondents know it is the leading cause of cancer death worldwide.

Fielded less than two weeks after the Vatican announced the Pope’s diagnosis, the poll found that roughly 60% of adults surveyed had at least heard about his diagnosis. But at the same time, just one in four poll respondents reported being familiar with the current lung cancer screening recommendations.

What’s more, people are not having important conversations about risk and screening with their doctors.  Our poll found that although 72% of American adults report having seen a primary care provider in the past year, only 14% reported that their doctor had discussed cancer screening options with them.

The results provide new urgency around raising awareness and educating the public.  

To that end, and as a key part of our long-term education and awareness focus, on November 5 the Foundation launched its own YouTube channel, with a trailer featuring some of the biggest YouTube stars (with over 800 million subscribers between them) joining community leaders and experts with clear, approachable content about lung cancer.

The channel aims to raise awareness and understanding of lung cancer by sharing credible, science-backed information, recent advances, and information challenging the misconceptions and stigma that have surrounded the disease for decades. We also aim to reach audiences who may not typically engage with traditional health and medical content by leveraging the authenticity, creativity, and reach of creators to make these important conversations more accessible and relatable.

YouTube is where people go to find community, share their stories, and look for answers, often before they ever talk to a doctor. The channel is paired with an online education hub offering clear information on lung cancer risk and screening that people can take to their doctors.

Why people who are eligible aren’t getting screened

For many people who are eligible for lung cancer screening, the first step is a conversation with a healthcare provider. But as our poll showed, too often, that conversation never happens.

There are many reasons for this. Screening eligibility can be complicated to assess, clinicians have limited time to discuss preventive care, and patients may not know that screening is available to them. Stigma can create another barrier. People may feel uncomfortable discussing their smoking history or worry about being judged.

Improving screening uptake requires making it easier for both clinicians and patients to take the next step. That means routinely assessing lung cancer risk, explaining why screening is recommended, approaching conversations about smoking history without judgment, and making screening easy to schedule and access.

These may seem like small changes, but together they could help more people who are eligible receive screening that could save their lives.

What would help

These questions aren't unique to the United States, and some countries are further along in answering them. In the United Kingdom, a national programme invites people at higher risk to come in for a lung health check, which is why it is important for health care providers to know when people are eligible. In Taiwan, where most lung cancers occur in people who never smoked, the national screening programme includes people with a family history of lung cancer. Other countries are building programmes of their own. Each is grappling with the same fundamental challenges: who qualifies for screening, how to ensure more people get screened, and how to improve awareness of screening recommendations.

None of this will change overnight. But each problem is one we can name, measure, and work on. Anyone with lungs can get lung cancer, and everyone deserves the chance to detect it early. When lung cancer is found early, it is more likely to be treated successfully.

 

Author(s):
Nadia Litterman
Dr Nadia Litterman
Executive Director of the Susan Wojcicki Foundation

Nadia Litterman, PhD, serves as Executive Director of the Susan Wojcicki Foundation, where she leads the foundation’s scientific strategy, organisational development, and cross-sector partnerships to advance innovation in lung cancer early detection and prevention.

Last update

Thursday 19 November 2026

Share this page